anastrozole has been researched along with Hemorrhage, Uterine in 6 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "To investigate the effect of switching from adjuvant tamoxifen to anastrozole (Arimidex) treatment in postmenopausal women with endocrine-responsive breast cancer and histologically proven tamoxifen-induced benign endometrial pathology." | 9.12 | Anastrozole versus tamoxifen treatment in postmenopausal women with endocrine-responsive breast cancer and tamoxifen-induced endometrial pathology. ( Gerber, B; Janni, W; Krause, A; Kundt, G; Makovitzky, J; Mylonas, I; Reimer, T, 2006) |
| "We report a long-term follow-up on the use of anastrozole in the treatment of peripheral precocious puberty (PP) in McCune-Albright syndrome (MAS)." | 7.78 | Partial benefit of anastrozole in the long-term treatment of precocious puberty in McCune-Albright syndrome. ( Alves, C; Silva, SF, 2012) |
| "Adjuvant therapy with anastrozole may be beneficial in resolving endometrial hyperplasia in patients with breast cancer." | 7.74 | Resolution of endometrial hyperplasia with adjuvant anastrozole treatment in postmenopausal breast cancer: a case report. ( Cooper, BC; Stilwill, SE, 2007) |
| "No difference in vaginal bleeding (mean number of days per year) was noted." | 5.35 | The aromatase inhibitor anastrozole is ineffective in the treatment of precocious puberty in girls with McCune-Albright syndrome. ( Eugster, EA; Lowe, ES; Mieszczak, J; Plourde, P, 2008) |
| "Women with hormone receptor (HR)-positive breast cancer who remained amenorrheic and had hormonal levels consistent with ovarian failure after adjuvant chemotherapy were enrolled in a multi-institutional clinical trial of anastrozole." | 5.17 | Predictors of recovery of ovarian function during aromatase inhibitor therapy. ( Banerjee, M; Gersch, C; Giacherio, D; Hayes, DF; Henry, NL; McConnell, D; Partridge, AH; Pearlman, M; Schott, AF; Stearns, V; Xia, R, 2013) |
| "To investigate the effect of switching from adjuvant tamoxifen to anastrozole (Arimidex) treatment in postmenopausal women with endocrine-responsive breast cancer and histologically proven tamoxifen-induced benign endometrial pathology." | 5.12 | Anastrozole versus tamoxifen treatment in postmenopausal women with endocrine-responsive breast cancer and tamoxifen-induced endometrial pathology. ( Gerber, B; Janni, W; Krause, A; Kundt, G; Makovitzky, J; Mylonas, I; Reimer, T, 2006) |
| "We report a long-term follow-up on the use of anastrozole in the treatment of peripheral precocious puberty (PP) in McCune-Albright syndrome (MAS)." | 3.78 | Partial benefit of anastrozole in the long-term treatment of precocious puberty in McCune-Albright syndrome. ( Alves, C; Silva, SF, 2012) |
| "Adjuvant therapy with anastrozole may be beneficial in resolving endometrial hyperplasia in patients with breast cancer." | 3.74 | Resolution of endometrial hyperplasia with adjuvant anastrozole treatment in postmenopausal breast cancer: a case report. ( Cooper, BC; Stilwill, SE, 2007) |
| "No difference in vaginal bleeding (mean number of days per year) was noted." | 1.35 | The aromatase inhibitor anastrozole is ineffective in the treatment of precocious puberty in girls with McCune-Albright syndrome. ( Eugster, EA; Lowe, ES; Mieszczak, J; Plourde, P, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Henry, NL | 1 |
| Xia, R | 1 |
| Banerjee, M | 1 |
| Gersch, C | 1 |
| McConnell, D | 1 |
| Giacherio, D | 1 |
| Schott, AF | 1 |
| Pearlman, M | 1 |
| Stearns, V | 1 |
| Partridge, AH | 1 |
| Hayes, DF | 1 |
| Koloszar, S | 1 |
| Pal, Z | 1 |
| Kereszturi, A | 1 |
| Vajda, G | 1 |
| Pal, A | 1 |
| Daru, J | 1 |
| Alves, C | 1 |
| Silva, SF | 1 |
| Gerber, B | 1 |
| Krause, A | 1 |
| Reimer, T | 1 |
| Mylonas, I | 1 |
| Makovitzky, J | 1 |
| Kundt, G | 1 |
| Janni, W | 1 |
| Stilwill, SE | 1 |
| Cooper, BC | 1 |
| Mieszczak, J | 1 |
| Lowe, ES | 1 |
| Plourde, P | 1 |
| Eugster, EA | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Aromatase Inhibitors in Premenopausal Breast Cancer Patients With Chemotherapy-Induced Ovarian Failure[NCT00555477] | Phase 2 | 69 participants (Actual) | Interventional | 2007-08-31 | Terminated (stopped due to The study was stopped after 69 subjects were enrolled because of poor accrual.) | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
In part 1 ovarian function recurrence is defined as one estradiol value >20 pg/ml or two consecutive values >10 pg/ml. In part 2 ovarian function recurrence is defined as a >75% increase in estradiol levels over prior if prior value was 15-30 pg/ml, or one estradiol value >30 pg/ml, or three consecutive values >20 pg/ml. (NCT00555477)
Timeframe: 12 months
| Intervention | participants (Number) |
|---|---|
| Anastrozole Part 1 | 8 |
| Anastrozole Part 2 | 13 |
2 trials available for anastrozole and Hemorrhage, Uterine
| Article | Year |
|---|---|
Predictors of recovery of ovarian function during aromatase inhibitor therapy.
Topics: Adult; Amenorrhea; Anastrozole; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; | 2013 |
Anastrozole versus tamoxifen treatment in postmenopausal women with endocrine-responsive breast cancer and tamoxifen-induced endometrial pathology.
Topics: Aged; Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Dilatation and Curettage; Endo | 2006 |
4 other studies available for anastrozole and Hemorrhage, Uterine
| Article | Year |
|---|---|
Effects of aromatase inhibitor on menopausal hyperplasia in a case of obesity.
Topics: Administration, Oral; Aged; Anastrozole; Aromatase Inhibitors; Atrophy; Endometrial Hyperplasia; End | 2012 |
Partial benefit of anastrozole in the long-term treatment of precocious puberty in McCune-Albright syndrome.
Topics: Age Determination by Skeleton; Anastrozole; Aromatase Inhibitors; Cafe-au-Lait Spots; Child, Prescho | 2012 |
Resolution of endometrial hyperplasia with adjuvant anastrozole treatment in postmenopausal breast cancer: a case report.
Topics: Anastrozole; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Endometrial Hyperplasia | 2007 |
The aromatase inhibitor anastrozole is ineffective in the treatment of precocious puberty in girls with McCune-Albright syndrome.
Topics: Anastrozole; Aromatase Inhibitors; Child; Child, Preschool; Female; Fibrous Dysplasia, Polyostotic; | 2008 |